Picture of Ion Beam Applications SA logo

IBAB — Ion Beam Applications SA News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Particle accelerator firm IBA's H1 revenue up 6% on equipment order intake growth

Particle accelerator firm IBA's H1 revenue up 6% on equipment order intake growth


Overview

  • Belgium particle accelerator firm's H1 revenue rose 6% yr/yr to €323.7 mln

  • Company posted net profit of €9.3 mln, reversing a loss in H1 2025

  • Full-year adjusted EBIT guidance of at least €32 mln reiterated


Outlook

  • IBA reiterates FY2026 adjusted EBIT guidance of at least €32 mln

  • Company expects net financial position to improve over 2027


Result Drivers

  • PROTON THERAPY PROFITABILITY - Co said improved execution and growing service activity in Proton Therapy drove higher profitability

  • EQUIPMENT ORDER INTAKE - Strong growth in equipment order intake, led by IBA Clinical, contributed to commercial momentum

  • GROSS MARGIN IMPROVEMENT - Higher gross margin was driven by equipment profitability mix and improved execution in Proton Therapy


Company press release: ID:nGNE3Bpysf


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

H1 Sales

EUR 323.70 mln

H1 Net Income

EUR 9.30 mln

H1 Gross Margin

33.70%

H1 Pretax Profit

EUR 12.30 mln


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"

  • Wall Street's median 12-month price target for Ion Beam Applications SA is €18.00, about 11.4% above its August 26 closing price of €16.16

  • The stock recently traded at 17 times the next 12-month earnings vs. a P/E of 13 three months ago


Reuters Recommended Reads

  • Aug 26 - Grand Pharmaceutical H1 revenue rises on nuclear medicine demand

  • Aug 26 - Belgium's DEME H1 net profit rises 20%

  • Aug 26 - Agilent raises annual profit forecast on improving lab tools demand


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Ion Beam Applications SA

See all news